Michael Saitakis
Company: Mnemo Therapeutics
Job title: Associate Director, Immunotherapy
Seminars:
Developing a Robust Tumour-Specific Target Discovery Platform for Next-Generation Immunotherapies 11:30 am
Utilising a high-throughput platform to screen disease tissues for novel target Determining which targets are best suited to CAR or TCR approaches Broadening repertoire of specific antigens to increase diversity of indication targetingRead more
day: Day 2 - Track A - AM